February 15, 2022 – The quarterly COSlaw appointment is back! You can find below a summary of what happened between October and December 2021. Check it to make sure you are updated!
If you have missed what happened before, you can catch up here.
Section 1 – What happened
In the first part of this article, you can find an overview of the news from Q4 2021. You will be re-directed to our articles and Watch-out Database for further details.
- On November 3, 2021, the European Commission published the Omnibus Act IV (Regulation (EU) 2021/1902), amending the Annexes to the EU Cosmetics Regulation. Twenty-three new cosmetic ingredients will be banned for use as of March 1, 2022. Among them: Butylphenyl Methylpropional (Lilial) and Zinc Pyrithione.
- In the context of the assessment of potential endocrine disruptors, the Scientific Committee on Consumer Safety (SCCS) issued the Final Opinion on Butylated Hydroxytoluene (BHT) and the Preliminary Opinions on 4-Methylbenzylidene camphor (4-MBC) and Kojic Acid.
Moreover, on November 11, 2021, the call for data concerning substances listed in Group B closed. The next step will be the safety assessment by the SCCS.
- The SCCS also delivered Final Opinions on HAA299 (nano) and Methyl salicylate, a Preliminary Opinion on Vitamin A (Retinol, Retinyl Acetate, Retinyl Palmitate), and Scientific Advice on the safety of Homosalate as a UV-filter in cosmetic products.
Additionally, the European Commission requested a scientific opinion on Butylparaben.
- The EU chemicals strategy for sustainability triggered a targeted revision of the EU Cosmetics Regulation. As a first step, the European Commission launched an Inception Impact Assessment from October 4, 2021, to November 1, 2021.
Section 2 – What is next
In the second part of this article, we give you hints on what is likely to happen soon. Check the list to be ready!
- The European Commission planned to transpose into the EU Cosmetics Regulation the conclusions of the SCCS concerning Methyl-N-methylanthranilate (M-N-MA). The new restrictions were scheduled for the first quarter of 2022 and were adopted on January 31.
- New restrictions for the UV filters Benzophenone-3 and Octocrylene are expected in the second quarter of 2022. The European Commission notified the WTO of the Regulation draft amending Annex VI to the EU Cosmetics Regulation.
- The European Commission wants to update the glossary of common ingredient names to harmonize labels and simplify ingredient identification. Hence, on January 6, 2022, the draft of the Commission Implementing Decision was notified to the WTO. Its adoption is planned for the second quarter of 2022, and the new glossary will apply 12 months after the Decision publication.
- Lastly, in September 2022, the European Commission will likely publish the Omnibus Act V that will apply as of December 17, 2022. Fourteen new ingredients will be banned in cosmetics, and Methyl salicylate will be subjected to restrictions depending on the cosmetic product types.
Obelis is a proud member of ERPA – the European Cosmetics Responsible Person Association. On February 2-3, 2022, ERPA held the Annual Congress on Regulations and Compliance for Cosmetics for the sixth year in a row. Cosmetics experts from the European Commission, national competent authorities, associations and Universities spoke about the sector’s hot topics, including Omnibus Acts, endocrine disruptors, and environmental claims.
You can still register to the Congress here and watch the live sessions and VOD presentations for two months. Do not miss this opportunity!
Follow COSlaw.eu to remain updated on the latest cosmetic news! Subscribe for free to our monthly newsletter, and you will receive in your email inbox a summary of everything we have published.